Revolutionizing Orthopedic Care:
The Mission of Four-Time Temple Graduate, Joseph C. McGinley, MD, PhD.
Learn how a four-time Temple University graduate (BS ‘96, MS ‘97, PhD ‘04, MD ‘04) is on a mission to change the standard of orthopedic care with innovative surgical tools.
Joseph C. McGinley, MD, PhD is on a mission. He wants to make a difference in as many patients’ lives as possible, beyond what he can do as a physician through his sports medicine practice. This mission started ten years ago when Dr. McGinley was at a dinner and heard of a 16 year-old patient who suffered a torn tendon from a mis-sized screw during a routine wrist fracture operation.
“I was perplexed why a teenager would experience a torn tendon from a routine screw placement procedure. These fractures are very common. I questioned if this adverse outcome was also prevalent. Unfortunately, I learned that misplaced screws happen at an alarmingly high rate due to outdated technology.”
After further research, Dr. McGinley discovered that the standard of care in orthopedic surgery had not changed in decades. The drill technology used in the operating room is no more advanced than the drill found in most garages. Relying on conventional technology contributes to 1 in 5 screws misplaced in orthopedic surgeries leading to $1.5B in preventable errors. Dr. McGinley saw the opportunity to deliver advanced orthopedic surgical tools and opened McGinley Orthopedics in Casper, Wyoming to work on solutions to these all-too-common problems.
Using his background in mechanical engineering, radiology, and sports medicine, Dr. McGinley and his team developed a new handheld robotic drill called IntelliSense Drill Technology® to eliminate the guesswork in orthopedic surgeries. Sensors integrated into the drill provide surgeons with real-time measurement to precisely size screws and feedback to safeguard against overdrilling. Both advancements would have helped to eliminate the errors suffered by the 16 year-old patient with a torn tendon.
McGinley Orthopedics manufactures the IntelliSense® Drill, along with 4 other orthopedic technologies, from its Casper headquarters. In-house manufacturing and product development allow the company to control the supply chain and avoid slow-downs seen in other industries reliant on a complex network of suppliers. It also has helped McGinley amass 71 patent families with 127 issued and pending patents to further impact the future of orthopedics.
The continued corporate innovation is not limited to products either. The company is also pioneering how they finance their growth, offering a unique investment opportunity through its current Regulation A+ crowdfunding campaign. Anyone can invest in the company, regardless of income or net worth, and be a part of its growth and success. This is a rare opportunity for individual retail investors to get in on the ground floor of a private, rapidly growing company with a $6 Billion market opportunity.
IN MAKING AN INVESTMENT DECISION, INVESTORS MUST RELY ON THEIR OWN EXAMINATION OF THE ISSUER AND THE TERMS OF THE OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED. REGULATION A OFFERINGS ARE SPECULATIVE, ILLIQUID, AND INVOLVE A HIGH DEGREE OF RISK, INCLUDING THE POSSIBLE LOSS OF YOUR ENTIRE INVESTMENT.
McGinley Orthopaedic Innovations is offering securities through the use of an Offering Statement that the Securities and Exchange Commission (‘SEC”) has qualified under Tier II of Regulation A. While the SEC staff reviews certain forms and filings for compliance with disclosure obligations, the SEC does not evaluate the merits of any offering, nor does it determine if any securities offered are “good” investments.
Rialto Markets LLC (“Rialto”) is registered with the Securities and Exchange Commission (“SEC”) as a broker-dealer, member of Financial Industry Regulatory Authority, Inc. (“FINRA”) and Securities Investor Protection Corporation (“SIPC”) and is the broker-dealer of record on this issuer direct offering.
This profile may contain forward-looking statements and information relating to, among other things, the company, its business plan and strategy, and its markets or industry. These statements reflect management’s current views regarding future events based on available information and are subject to risks and uncertainties that could cause the company’s actual results to differ materially. Investors are cautioned not to place undue reliance on these forward-looking statements as they are
meant for illustrative purposes, and they do not represent guarantees of future results, levels of activity, performance, or achievements, all of which cannot be made. Moreover, although management believes that the expectations reflected in the forward-looking statements are reasonable, neither McGinley Orthopaedic Innovations nor anyone acting on its behalf can give any assurance that such expectations will prove to have been correct nor do they have a duty to update any such statements to conform them to actual results.